Cardiotrophin-1 is associated with increased risk of arterial stiffness

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aim: Cardiotrophin-1 null mice presented decreased arterial stiffness. The aim of this study is to investigate the relationship between cardiotrophin-1 and arterial stiffness, assessed by brachial-ankle pulse-wave velocity (baPWV). Methods: We enrolled 300 subjects, 200 with baPWV >1400 and 100 with baPWV ≤1400 cm/s. Results: Cardiotrophin-1 levels were significantly higher in subjects with baPWV >1400 than those with baPWV ≤1400 cm/s. The multivariate logistic regression analysis showed that age, prehypertension, hypertension and cardiotrophin-1 were independently associated with baPWV >1400 cm/s after adjusting for gender, obesity, diabetes, homeostasis model assessment-insulin resistance, total cholesterol, high-density lipoprotein cholesterol, triglyceride, high-sensitivity C-reactive protein, creatinine, smoking and habitual exercise. Conclusion: Cardiotrophin-1 is positively related to baPWV independent of traditional cardiometabolic risk factors for arterial stiffness.

Original languageEnglish
Pages (from-to)123-130
Number of pages8
JournalBiomarkers in Medicine
Volume9
Issue number2
DOIs
Publication statusPublished - 2015 Feb 1

Fingerprint

Pulse Wave Analysis
Vascular Stiffness
Ankle
Arm
Stiffness
Prehypertension
Cholesterol
Medical problems
cardiotrophin 1
Regression analysis
C-Reactive Protein
HDL Cholesterol
Insulin Resistance
Logistics
Creatinine
Triglycerides
Homeostasis
Obesity
Logistic Models
Smoking

All Science Journal Classification (ASJC) codes

  • Drug Discovery
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

@article{9b2c83d1af5a41eebf447e71f459b724,
title = "Cardiotrophin-1 is associated with increased risk of arterial stiffness",
abstract = "Aim: Cardiotrophin-1 null mice presented decreased arterial stiffness. The aim of this study is to investigate the relationship between cardiotrophin-1 and arterial stiffness, assessed by brachial-ankle pulse-wave velocity (baPWV). Methods: We enrolled 300 subjects, 200 with baPWV >1400 and 100 with baPWV ≤1400 cm/s. Results: Cardiotrophin-1 levels were significantly higher in subjects with baPWV >1400 than those with baPWV ≤1400 cm/s. The multivariate logistic regression analysis showed that age, prehypertension, hypertension and cardiotrophin-1 were independently associated with baPWV >1400 cm/s after adjusting for gender, obesity, diabetes, homeostasis model assessment-insulin resistance, total cholesterol, high-density lipoprotein cholesterol, triglyceride, high-sensitivity C-reactive protein, creatinine, smoking and habitual exercise. Conclusion: Cardiotrophin-1 is positively related to baPWV independent of traditional cardiometabolic risk factors for arterial stiffness.",
author = "Hao-Chang Hung and Feng-Hwa Lu and Horng-Yih Ou and Wu, {Hung Tsung} and Jin-Shang Wu and Yi-Ching Yang and Chih-Jen Chang",
year = "2015",
month = "2",
day = "1",
doi = "10.2217/BMM.14.87",
language = "English",
volume = "9",
pages = "123--130",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Cardiotrophin-1 is associated with increased risk of arterial stiffness

AU - Hung, Hao-Chang

AU - Lu, Feng-Hwa

AU - Ou, Horng-Yih

AU - Wu, Hung Tsung

AU - Wu, Jin-Shang

AU - Yang, Yi-Ching

AU - Chang, Chih-Jen

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Aim: Cardiotrophin-1 null mice presented decreased arterial stiffness. The aim of this study is to investigate the relationship between cardiotrophin-1 and arterial stiffness, assessed by brachial-ankle pulse-wave velocity (baPWV). Methods: We enrolled 300 subjects, 200 with baPWV >1400 and 100 with baPWV ≤1400 cm/s. Results: Cardiotrophin-1 levels were significantly higher in subjects with baPWV >1400 than those with baPWV ≤1400 cm/s. The multivariate logistic regression analysis showed that age, prehypertension, hypertension and cardiotrophin-1 were independently associated with baPWV >1400 cm/s after adjusting for gender, obesity, diabetes, homeostasis model assessment-insulin resistance, total cholesterol, high-density lipoprotein cholesterol, triglyceride, high-sensitivity C-reactive protein, creatinine, smoking and habitual exercise. Conclusion: Cardiotrophin-1 is positively related to baPWV independent of traditional cardiometabolic risk factors for arterial stiffness.

AB - Aim: Cardiotrophin-1 null mice presented decreased arterial stiffness. The aim of this study is to investigate the relationship between cardiotrophin-1 and arterial stiffness, assessed by brachial-ankle pulse-wave velocity (baPWV). Methods: We enrolled 300 subjects, 200 with baPWV >1400 and 100 with baPWV ≤1400 cm/s. Results: Cardiotrophin-1 levels were significantly higher in subjects with baPWV >1400 than those with baPWV ≤1400 cm/s. The multivariate logistic regression analysis showed that age, prehypertension, hypertension and cardiotrophin-1 were independently associated with baPWV >1400 cm/s after adjusting for gender, obesity, diabetes, homeostasis model assessment-insulin resistance, total cholesterol, high-density lipoprotein cholesterol, triglyceride, high-sensitivity C-reactive protein, creatinine, smoking and habitual exercise. Conclusion: Cardiotrophin-1 is positively related to baPWV independent of traditional cardiometabolic risk factors for arterial stiffness.

UR - http://www.scopus.com/inward/record.url?scp=84923457688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923457688&partnerID=8YFLogxK

U2 - 10.2217/BMM.14.87

DO - 10.2217/BMM.14.87

M3 - Article

C2 - 25689900

AN - SCOPUS:84923457688

VL - 9

SP - 123

EP - 130

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 2

ER -